Omikenshi

Omikenshi is a Japanese materials science and textile company that has diversified into the healthcare and functional food sectors. The company is best known in the life sciences for its proprietary "Crabyon" technology, which integrates chitin and chitosan into cellulose fibers to create antibacterial and hypoallergenic textiles used in medical garments and wound dressings. Beyond textiles, Omikenshi develops health-focused food products, including low-carbohydrate konjac-based alternatives designed for weight management and diabetic diets. Although the company faced significant financial restructuring and was delisted from the Tokyo Stock Exchange in 2023, it continues to operate its functional materials and healthcare divisions. Its business model focuses on leveraging traditional fiber expertise to address modern health and hygiene needs.